Human genome project and cystic fibrosis - A symbiotic relationship

Journal of the American Dietetic Association

Volumn 99, Issue 11, 1999, Pages 1421-1427

  Tolstoi, Linda G ^a,c   Smith, Cassandra L ^b  

^a Boston University   (United States)

^b BOSTON UNIVERSITY   (United States)

^c NONE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BIOTECHNOLOGY; CYSTIC FIBROSIS; DIET THERAPY; GENE MAPPING; GENE SEQUENCE; GENE THERAPY; GENETIC ANALYSIS; GENETIC LINKAGE; HUMAN; REVIEW;

EID: 0032716930     PISSN: 00028223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-8223(99)00343-0     Document Type: Review

References (62)

1. Carlson EA. Defining the gene: an evolving concept. Am J Hum Genet. 1991;49:457-487.
2. Short N. On first looking into the human genome. Nature. 1995;377(6547 suppl):1.
3. Sawicki MP, Samara G, Hurwitz M, Passaro E Jr. Human genome project. Am J Surg. 1993;165:258-264.
4. Jaroff L. Double helixes, scissors, and RFLPs. In: The New Genetics. Knoxville, Tenn: Grand Rounds Press; 1991:14-24.
5. Francomano CA, Collins FA. The human genome project: implications for medical practice. Today's Internist. 1997;38(6):11-15.
6. The Human Genome Project: From Maps to Medicine. Bethesda, Md: Dept of Health and Human Services, Public Health Service, National Institutes of Health; 1996. NIH publication No. 96-3897.
7. Jordan E. The human genome project: Where did it come from, where is it going? Am J Hum Genet. 1992;51:1-6.
8. Vaugh D, ed. To Know Ourselves. Washington, DC: US Dept of Energy and Human Genome Project; 1996:2-34. DOE/LBNL PUB-773.
9. Casey D. Primer on Molecular Genetics. Washington, DC: US Dept of Energy, Office of Energy Research, Office of Health and Environmental Research; 1992:3-40.
10. Collins FS. Sequencing the human genome. Hosp Pract. 1997;32:35-43,46-49,53-54.
11. Haq MM. Medical genetics and the human genome project: a historical review. Texas Med. 1993;89:68-73.
12. Smith CL, Olvia R, Lawrance SK, Wang D. Chromosomes, molecular studies. In: Dulbecco R, ed. Encyclopedia of Human Biology. 2nd ed. VoL 2. New YorK, NY Academic Press; 1997:781-796.
13. Smith CL, Cantor CR. Consequences of mapping and sequencing the human genome for neurologic diseases. In: Rosenberg RN, Prusiner SB, DiMauro S, Brachi RL, eds. The Molecular and Genetic Basis of Neurological Disease. 2nd ed. Boston, Mass: Butterworth-Heinemann; 1997:1375-1388.
14. Collins F, Gales D. A new five-year plan for the US human genome project. Science. 1993;262:43-46.
15. Green ED, Waterston RH. The human genome project: prospects and implications for clinical medicine. JAMA. 1991;266:1966-1975.
16. Passaro E Jr, Hurwitz M, Samara G, Sawicki M. Molecular biology: an overview. Am J Surg. 1992;164:146-152.
17. Micklos DA, Freyer GA. Basic tools and techniques of DNA science. In: DAM Science: A First Course in Recombinant DNA Technology. Burlington, NC: Carolina Biological Supply Co; 1990:39-60.
18. Billings PR, Smith CL, Cantor CR. New techniques for physical mapping of the human genome. FASEB J. 1991;5:28-34.
19. Layman LC. Basic concepts of DNA diagnosis for clinicians. The Female Patient (Ob/Gyn edition). 1995;20:15-16,19-20,23-24,26,28,75-77.
20. Eisenstein Bl. The polymerase chain reaction: a new method of using molecular genetics for medical diagnosis. N Engl J Med. 1990;322:178-183.
21. Micklos DA, Freyer GA. Glossary/index. In: DNA Science: A First Course in Recombinant DNA Technology. Burlington, NC: Carolina Biological Supply Co; 1990:463-477.
22. Burke DT, Carle GF, Olson MV. Cloning of large segments of exogenous DNA into yeast by means of artificial chromosome vectors. Science. 1987;236:809-812.
23. Watson JD, Gilman M, Witoski J, Zoller M. Recombinant DNA in medicine and industry. In: Recombinant DNA. 2nd ed. New York, NY: WH Freeman & Co; 1990:453-470
24. Maxam AM, Gilbert W. A new method for sequencing DNA. Proc Natl Acad Sci U S A. 1977;74:560-564.
25. Cantor CR, Tang K, Graber JM, Maloney M, Fu DJ, Broude NE, Siddiqi F, Koester H, Smith CL. DNA sequencing after the human genome project. Nucleosides Nucleotides. 1997;16:591-598.
26. Davis PB. Cystic fibrosis: new perceptions, new strategies. Hosp Pract. 1992;27:79-83,87,88,93,94,100,103,106,112,115,116,118.
27. Andersen DH. Cystic fibrosis of the pancreas and its relation to celiac disease: a clinical and pathologic study. Am J Dis Child. 1938;56:344-399.
28. Tsui L-C, Durie P. Genotype and phenotype in cystic fibrosis. Hosp Pract. 1997;32:115-118,123-129,134,140,142.
29. Quinton PM. Cystic fibrosis: a disease in electrolyte transport. FASEB J. 1990;4:2709-2717
30. White R. The search for the cystic fibrosis gene. Science. 1986;234:1054-1055.
31. Davis PB, Drumm M, Konstan MW. Cystic fibrosis. Am J Respir Crit Care Med. 1997;154:1229-1256.
32. Rationale for the use of human deoxyribonuclease I (rhDNase-pulmozyme) in patients with cystic fibrosis. In: Consensus Conferences. Concepts in Care. Bethesda, Md: Cystic Fibrosis Foundation; 1993. IV (sec 1):1-6.
33. Tsui L-C, Buchwald M, Barker D, Braman JC, Knowlton R, Schumm JW, Eiberg H, Mohr J, Kennedy D, Plavsic N, Zsiga M, Markiewicz D, Akots G, Brown V, Helms C, Gravius T, Parker C, Rediker K, Donis-Keller H. Cystic fibrosis defined by a genetically linked polymorphic DNA marker. Science. 1985;230:1054-1057.
34. Rommens JM, Iannuzzi MC, Kerem B-S, Drumm ML, Melmer G, Dean M, Rozmahel R, Cole JL, Kennedy D, Hidaka N, Zsiga M, Buchwald M, Riordian JR, Tsui L-C, Collins FS. Identification of the cystic fibrosis gene: chromosome walking and jumping. Science. 1989;245:1059-1065.
35. Collins FS. Positional cloning: let's not call it reverse anymore. Nature Genet. 1992;1:3-6.
36. Iannuzzi MC, Collins FS. Reverse genetics and cystic fibrosis. Am J Respir Cell Mol Biol. 1990;2:309-316.
37. McKusick VA. Genomic mapping and how it has progressed. Hosp Pract. 1991;26:74-84,89-90.
38. Riordan JR, Rommens JM, Kerem B-S, Alon N, Rozmahel R, Grzelczak Z. Zielenski J, Lok S, Plavsic N, Chou J-L, Drumm ML, lannuzzi MC, Collins FS, Tsui L-C. Identification of the cystic fibrosis gene: cloning and characterization of complementary DNA. Science. 1989;245:1066-1073.
39. Kerem B-S, Rommens JM, Buchanan JA, Markiewicz D, Cox TK, Chakravarti A, Buchwald M, Tsui L-C. Identification of the cystic fibrosis gene: genetic analysis. Science, 1989;245:1073-1080.
40. Fink L, Collins FS. The human genome project: view from the National Institutes of Health. J Am Med Woman Assoc. 1997;52:4-7,15.
41. Robinson C. Scanlin TF. Cystic fibrosis. In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM, eds. Fishman's Pulmonary Diseases & Disorders. 3rd ed. New York, NY: McGraw Hill; 1998:803-824.
42. Creveling S, Light M, Gardner P, Greene L. Cystic fibrosis, nutrition and health care team. J Am Diet Assoc. 1997;97(suppl):S186-S191.
43. Michel MH, Stevens JC, eds. Cystic Fibrosis: The Impact of Nurses on Patient Management. San Francisco, Calif: Genentech; 1996:1-32
44. Shak S, Capon DJ, Hellmiss R, Marsters SA, Baker CL. Recombinant human DNase I reduces the viscosity of cystic fibrosis sputum. Proc Natl Acad Sci U S A. 1990;87:9188-9192.
45. Shak S. Aerosolized recombinant human DNase I for the treatment of cystic fibrosis. Chest. 1995;107(suppl):65S-70S.
46. Duplantier D, McWaters DS. Cystic fibrosis: progress against a childhood killer. US Pharm. 1992;17:34-36,41,42,44,46,48-50,63,64.
47. Aitken ML, Fiel SB. Cystic fibrosis. Dis Mon. 1993;39(1):6-52.
48. Fiel SB. Aerosol delivery of antibiotics to lower airways of patients with cystic fibrosis. Chest. 1995;107(suppl):61S-64S.
49. Rosenstein BJ, Eigen H. Risk of alternate-day prednisone in patients with cystic fibrosis. Pediatrics. 1991;87:245-246.
50. Dowsett J. Nutrition in the management of cystic fibrosis. Nutr Rev. 1996;54(1 pt 1):31-33.
51. Rothbaum RJ. Improving digestion in children with cystic fibrosis. Contemp Pediatr. 1996;13:39,42,45,46,48,50,52-54.
52. Warwick WJ. Diet for cystic fibrosis. Postgrad Med. 1987;82:121-124,126,129-130.
53. MacSweeney EJ, Oades PJ, Buchdahl R, Rosenthal M, Bush A. Relation of thickening of colon wall to pancreatic-enzyme treatment in cystic fibrosis. Lancet. 1995;345:752-756.
54. Smyth RL, van Velzen D, Smyth RA, Lloyd DA, Heaf DP. Strictures of ascending colon in cystic fibrosis and high-strength enzymes. Lancet. 1994;343:85-86.
55. MacDonald A. Nutritional management of cystic fibrosis. Arch Dis Child. 1996;74:81-87.
56. Steinkamp G, Drommer A, von der Hardt H. Resting energy expenditures before and after treatment for Pseudomonas aeruginosa infection in patients with cystic fibrosis. Am J Clin Nutr. 1993;57:685-689.
57. Ramsey BW, Farrell PM, Pencharz P, and the Consensus Committee. Nutritional assessment and management in cystic fibrosis: a consensus report. Am J Clin Nutr. 1992;55:108-116.
58. MacLusky I. Cystic fibrosis for the primary care pediatrician. Pediatr Ann. 1993;22:541,542,544-546,548,549.
59. Welsh MJ, Tsui L-C, Boat TF, Beaudet AL. Cystic fibrosis. In: Scriver CR, Beaudet AL, Sly WS, Valle D, eds. The Metabolic and Molecular Basis of Inherited Disease. 7th ed. Boston, Mass: McGraw Hill; 1995:3799-3876.
60. Rosenfeld MA, Collins FS. Gene therapy for cystic fibrosis. Chest. 1996;109:241-252.
61. Wilson JM, Wilson CB. Cystic fibrosis: pointing to the medicine of the future. In: Highlights (Selected Proceedings from the Tenth Annual North American Cystic Fibrosis Conference, October24-27, 1996). Bethesda, Md: Cystic Fibrosis Foundation; 1997:1-2.
62. SimonRH. Issues in the management of adults with CF.In:Highlights(Selected Proceedings from the Tenth Annual North American Cystic Fibrosis Conference, October 24-27, 1996). Bethesda, Md: Cystic Fibrosis Foundation; 1997:21-22.